AlzChem Group AG (ACT:XETRA) Annual Income Statement ()
ACT:XETRA Quarterly Financials ()
Frequently Asked Questions About AlzChem Group AG (ACT:XETRA) Stock
AlzChem Group AG's (ACT:XETRA) last reported annual revenue was EUR 540.65 Million.
AlzChem Group AG's (ACT:XETRA) annual revenue growth rate based on the revenue reported in the past 5 years is : 7.58%
AlzChem Group AG's(ACT:XETRA) is profitable as of its last reported annual financials.
The net profit margin for AlzChem Group AG's(ACT:XETRA) from its laster reported year is 6.40%
The return on equity (ROE) for AlzChem Group AG's(ACT:XETRA) from its last reported annual financials is : 23.81%
The return on assets (ROA) for AlzChem Group AG's(ACT:XETRA) from its last reported annual financials is : 8.43%
The return on invested capital (ROIC) for AlzChem Group AG's(ACT:XETRA) from its last reported annual financials is : 19.06%
The Debt to Equity ratio for AlzChem Group AG's(ACT:XETRA) from its last reported annual financials is : 30.11%
The dividend yield for AlzChem Group AG's(ACT:XETRA) from its laster reported year is 2.74%
AlzChem Group AG's(ACT:XETRA) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ACT:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
